120 related articles for article (PubMed ID: 15827551)
1. Effects of cisplatin on olfactory function in cancer patients.
Yakirevitch A; Talmi YP; Baram Y; Weitzen R; Pfeffer MR
Br J Cancer; 2005 May; 92(9):1611-3. PubMed ID: 15827551
[TBL] [Abstract][Full Text] [Related]
2. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
3. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
4. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
5. [Effects of high-doses cisplatin on the auditory function in children].
Stura M; Tarantino V; Perin GP; Dallorso S; Haupt R
Minerva Pediatr; 1986 Nov; 38(22):1069-74. PubMed ID: 3807851
[No Abstract] [Full Text] [Related]
6. Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimen.
Arora R; Thakur JS; Azad RK; Mohindroo NK; Sharma DR; Seam RK
Indian J Cancer; 2009; 46(4):311-7. PubMed ID: 19749461
[TBL] [Abstract][Full Text] [Related]
7. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
Zuur CL; Simis YJ; Verkaik RS; Schornagel JH; Balm AJ; Dreschler WA; Rasch CR
Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin chemotherapy induces odor perception changes in bronchial cancer patients.
Joussain P; Giboreau A; Fontas M; Laville M; Hummel T; Souquet PJ; Bensafi M
Lung Cancer; 2013 Oct; 82(1):168-70. PubMed ID: 23896024
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors.
Oldenburg J; Kraggerud SM; Cvancarova M; Lothe RA; Fossa SD
J Clin Oncol; 2007 Feb; 25(6):708-14. PubMed ID: 17228018
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity in children treated for osteosarcoma.
Lewis MJ; DuBois SG; Fligor B; Li X; Goorin A; Grier HE
Pediatr Blood Cancer; 2009 Mar; 52(3):387-91. PubMed ID: 19061216
[TBL] [Abstract][Full Text] [Related]
11. What is the correlation between ratings and measures of olfactory function in patients with olfactory loss?
Welge-Luessen A; Hummel T; Stojan T; Wolfensberger M
Am J Rhinol; 2005; 19(6):567-71. PubMed ID: 16402642
[TBL] [Abstract][Full Text] [Related]
12. [Investigation for relation of gustatory and olfactory impairment in patients receiving cancer chemotherapy].
Suga Y; Kitade H; Kawagishi A; Takeda K; Haruki K; Ishizaki J; Sai Y; Kasahara K; Arai K; Miyamoto K
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2617-21. PubMed ID: 22189228
[TBL] [Abstract][Full Text] [Related]
13. Olfactory changes among patients receiving chemotherapy.
Bernhardson BM; Tishelman C; Rutqvist LE
Eur J Oncol Nurs; 2009 Feb; 13(1):9-15. PubMed ID: 19028142
[TBL] [Abstract][Full Text] [Related]
14. [Can lacidipine cause smell disorders? A case report].
Lulić I; Ković I
Lijec Vjesn; 2011; 133(3-4):98-100. PubMed ID: 21612105
[TBL] [Abstract][Full Text] [Related]
15. Hearing loss in pediatric cancer survivors treated with cisplatin.
Knight K
Oncology (Williston Park); 2008 Apr; 22(4 Suppl Nurse Ed):35-7. PubMed ID: 19856560
[No Abstract] [Full Text] [Related]
16. Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer.
Liao XB; Yan SX
Radiother Oncol; 2009 Feb; 90(2):282, author reply 282-3. PubMed ID: 19042049
[No Abstract] [Full Text] [Related]
17. Differences between orthonasal and retronasal olfactory functions in patients with loss of the sense of smell.
Landis BN; Frasnelli J; Reden J; Lacroix JS; Hummel T
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):977-81. PubMed ID: 16301369
[TBL] [Abstract][Full Text] [Related]
18. Olfactory function following nasal surgery.
Pade J; Hummel T
Laryngoscope; 2008 Jul; 118(7):1260-4. PubMed ID: 18438263
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hearing loss in children receiving cisplatin chemotherapy.
Freyer DR; Sung L; Reaman GH
J Clin Oncol; 2009 Jan; 27(2):317-8; author reply 318-9. PubMed ID: 19064953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
